Rosen, global investor counsel, continues its investigation of securities claims against sonoma pharmaceuticals, inc. - snoa

New york, new york--(newsfile corp. - december 8, 2020) - rosen law firm, a global investor rights law firm, continues its investigation of potential securities claims on behalf of shareholders of sonoma pharmaceuticals, inc. (nasdaq: snoa) resulting from allegations that sonoma may have issued materially misleading business information to the investing public.on november 17, 2020, after market hours, sonoma filed a form 8-k with the u.s. securities and exchange commission announcing that sonoma's "unaudited...
SNOA Ratings Summary
SNOA Quant Ranking